Study on Predicting Sudden Cardiac Death Risk in Patients with Moderate LVEF
The study aims to identify markers that predict the risk of sudden cardiac death in patients with moderate left ventricular ejection fraction (LVEF) post-myocardial infarction.
Phase III
Cardiology / Sudden Cardiac Death
Status
Active
Signal Score
8.4
Signal assessment
Signal strength
high
Confidence level
high
Why it matters
This study addresses a critical gap in the risk assessment of sudden cardiac death in post-myocardial infarction patients with moderate LVEF. Successful identification of new risk markers could significantly influence clinical practices and treatment protocols in cardiology, particularly regarding the use of implantable defibrillators.
Recommended action
Humanexa recommends Monitor.
Analysis
Monitor the study's progress and results for new risk markers and their implications for clinical practice.
Related companies & assets
Sources & Humanexa intelligence
Related signals
Newsletter
Get signals before the market moves
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.